{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,12,7]],"date-time":"2024-12-07T00:10:18Z","timestamp":1733530218622,"version":"3.30.1"},"reference-count":24,"publisher":"Elsevier BV","issue":"5-6","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T00:00:00Z","timestamp":1731024000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JMV-Journal de M\u00e9decine Vasculaire"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.jdmv.2024.11.001","type":"journal-article","created":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T22:19:28Z","timestamp":1732141168000},"page":"211-218","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Unresolved issues concerning venous thromboembolism. Venous thromboembolism in children. Consensus of the French Society of Vascular Medicine (SFMV)"],"prefix":"10.1016","volume":"49","author":[{"given":"Sophie","family":"Blaise","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabrielle","family":"Sarlon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marjolaine","family":"Talbot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillaume","family":"Mah\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Bura-Rivi\u00e8re","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdmv.2024.11.001_bib0125","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1542\/peds.2009-0768","article-title":"Dramatic increase in venous thromboembolism in children's hospitals in the United States from 2001 to 2007","volume":"124","author":"Raffini","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.jdmv.2024.11.001_bib0130","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jpeds.2016.02.017","article-title":"Incidence trends and mortality from childhood venous thromboembolism: a population-based cohort study","volume":"172","author":"Sabapathy","year":"2016","journal-title":"J Pediatr"},{"key":"10.1016\/j.jdmv.2024.11.001_bib0135","doi-asserted-by":"crossref","first-page":"3292","DOI":"10.1182\/bloodadvances.2018024786","article-title":"American Society of Hematology 2018 Guidelines for management of venous thromboembolism: treatment of pediatric venous thromboembolism","volume":"2","author":"Monagle","year":"2018","journal-title":"Blood Adv"},{"key":"10.1016\/j.jdmv.2024.11.001_bib0140","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/MBC.0b013e3283424824","article-title":"Venous thrombosis in children: an emerging issue","volume":"22","author":"Molinari","year":"2011","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.jdmv.2024.11.001_bib0145","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1055\/s-0036-1593415","article-title":"Neonatal hemostatic disorders: issues and challenges","volume":"42","author":"Hanmod","year":"2016","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jdmv.2024.11.001_bib0150","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/MBC.0b013e328364f9b0","article-title":"Neonatal central venous catheter thrombosis: diagnosis, management and outcome","volume":"25","author":"Park","year":"2014","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.jdmv.2024.11.001_bib0155","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1111\/bjh.15060","article-title":"Advances in predicting venous thromboembolism risk in children","volume":"180","author":"R\u00fchle","year":"2018","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jdmv.2024.11.001_bib0160","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1182\/blood-2006-04-015511","article-title":"Thrombotic complications in childhood acute lymphoblastic leukemia: a meta-analysis of 17 prospective studies comprising 1752 pediatric patients","volume":"108","author":"Caruso","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.jdmv.2024.11.001_bib0165","doi-asserted-by":"crossref","first-page":"e28957","DOI":"10.1002\/pbc.28957","article-title":"The incidence and risk factors for venous thromboembolism in adolescent and young adult oncology patients","volume":"68","author":"Hsiao","year":"2021","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jdmv.2024.11.001_bib0170","doi-asserted-by":"crossref","first-page":"e2011025","DOI":"10.4084\/mjhid.2011.025","article-title":"Thalassemia and venous thromboembolism","volume":"3","author":"Succar","year":"2011","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"10.1016\/j.jdmv.2024.11.001_bib0175","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1182\/asheducation-2018.1.399","article-title":"Management of thrombosis in children and neonates: practical use of anticoagulants in children","volume":"2018","author":"Monagle","year":"2018","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.jdmv.2024.11.001_bib0180","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1203\/00006450-199401000-00016","article-title":"Heparin therapy in pediatric patients: a prospective cohort study","volume":"35","author":"Andrew","year":"1994","journal-title":"Pediatr Res"},{"key":"10.1016\/j.jdmv.2024.11.001_bib0185","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/j.1440-1754.2011.02127.x","article-title":"Infant deaths due to heparin overdose: time for a concerted action on prevention","volume":"48","author":"Monagle","year":"2012","journal-title":"J Paediatr Child Health"},{"key":"10.1016\/j.jdmv.2024.11.001_bib0190","doi-asserted-by":"crossref","first-page":"e737S","DOI":"10.1378\/chest.11-2308","article-title":"Antithrombotic therapy in neonates and children: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of chest physicians evidence-based clinical practice guidelines","volume":"141","author":"Monagle","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.jdmv.2024.11.001_bib0195","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.pharma.2021.02.007","article-title":"Enoxaparin and tinzaparin in pediatrics: Impact of recommendation on prescription quality and anti-Xa levels","volume":"79","author":"Noailly","year":"2021","journal-title":"Ann Pharm Fr"},{"key":"10.1016\/j.jdmv.2024.11.001_bib0200","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0049-3848(03)00059-8","article-title":"An open-label randomized controlled trial of low molecular weight heparin compared to heparin and coumadin for the treatment of venous thromboembolic events in children: the REVIVE trial","volume":"109","author":"Massicotte","year":"2003","journal-title":"Thromb Res"},{"key":"10.1016\/j.jdmv.2024.11.001_bib0205","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.acvd.2020.05.022","article-title":"Health-related quality of life correlates with time in therapeutic range in children on anticoagulants with International Normalised Ratio self-monitoring","volume":"113","author":"Abassi","year":"2020","journal-title":"Arch Cardiovasc Dis"},{"key":"10.1016\/j.jdmv.2024.11.001_bib0210","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1111\/jth.14813","article-title":"Rivaroxaban for treatment of pediatric venous thromboembolism. An Einstein-Jr phase 3 dose-exposure-response evaluation","volume":"18","author":"Young","year":"2020","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jdmv.2024.11.001_bib0215","unstructured":"XARELTO (rivaroxaban)\u00a0\u2013\u00a0\u00e9v\u00e8nements thromboemboliques veineux (ETEV) p\u00e9diatrique. Haute Autorit\u00e9 de sant\u00e9, https:\/\/www.has-sante.fr\/jcms\/p_3272782\/fr\/xarelto-rivaroxaban-evenements-thromboemboliques-veineux-etev-pediatrique (accessed 21 April 2023)."},{"key":"10.1016\/j.jdmv.2024.11.001_bib0220","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1055\/s-0038-1668132","article-title":"Anticoagulant effects of dabigatran in paediatric patients compared with adults: combined data from three paediatric clinical trials","volume":"118","author":"Maas","year":"2018","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jdmv.2024.11.001_bib0225","unstructured":"Bristol-Myers Squibb. A randomized, open-label, active controlled, safety and descriptive efficacy study in pediatric subjects requiring anticoagulation for the treatment of a venous thromboembolic event. Clinical Trial Registration NCT02464969, clinicaltrials.gov, https:\/\/clinicaltrials.gov\/study\/NCT02464969 (6 February 2023, accessed 8 August 2023)."},{"key":"10.1016\/j.jdmv.2024.11.001_bib0230","unstructured":"Daiichi Sankyo, Inc. A phase 3, open-label, randomized, multi-center, controlled trial to evaluate the pharmacokinetics and pharmacodynamics of edoxaban and to compare the efficacy and safety of edoxaban with standard of care anticoagulant therapy in pediatric subjects from birth to less than 18 years of age with confirmed venous thromboembolism (VTE). Clinical trial registration NCT02798471, clinicaltrials.gov, https:\/\/clinicaltrials.gov\/study\/NCT02798471 (3 February 2023, accessed 8 August 2023)."},{"key":"10.1016\/j.jdmv.2024.11.001_bib0235","unstructured":"Gislason G. The Danish non-vitamin K antagonist oral anticoagulation study. A cluster randomized study comparing safety and efficacy of edoxaban, apixaban, rivaroxaban and dabigatran for oral anticoagulation in patients with venous thromboembolism. Clinical trial registration NCT03129555, clinicaltrials.gov, https:\/\/clinicaltrials.gov\/study\/NCT03129555 (5 July 2023, accessed 8 August 2023)."},{"key":"10.1016\/j.jdmv.2024.11.001_bib0240","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1001\/jama.2021.23182","article-title":"Effect of anticoagulant therapy for 6 weeks vs 3 months on recurrence and bleeding events in patients younger than 21 years of age with provoked venous thromboembolism: the Kids-DOTT randomized clinical trial","volume":"327","author":"Goldenberg","year":"2022","journal-title":"JAMA"}],"container-title":["JMV-Journal de M\u00e9decine Vasculaire"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2542451324001597?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2542451324001597?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T23:45:08Z","timestamp":1733528708000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2542451324001597"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":24,"journal-issue":{"issue":"5-6","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S2542451324001597"],"URL":"https:\/\/doi.org\/10.1016\/j.jdmv.2024.11.001","relation":{},"ISSN":["2542-4513"],"issn-type":[{"type":"print","value":"2542-4513"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unresolved issues concerning venous thromboembolism. Venous thromboembolism in children. Consensus of the French Society of Vascular Medicine (SFMV)","name":"articletitle","label":"Article Title"},{"value":"JMV-Journal de M\u00e9decine Vasculaire","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdmv.2024.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}